SBA Academy: Challenges in Drug Discovery and Development

Newstemp_default.html

Module 4: Clinical Development

CHF 150.00 for members of SBA, swiTT, CTI-start-up companies and academia

This seminar day will focus on challenges and issues for small biotech and academia entering clinical development:

  • Pharma R&D: Issues and Perspectives (Walid Abi-Saab, Shire Pharmaceuticsl)
  • Clinical Phase I-II:
    Phase I/II clinical Trials in the Academic Setting - Benefits for Researchs and Industry(Michael Weisskopf, CTC Zürich)
    Case Presentation (Anya Hamman-Hänni, Cytos)
  • Clinical Phase III:
    Prove Safety & Efficacy in a Large Patient Population (Stephanie Sauter, Five Office)
    Case Presentation: Marc Urich, Swiss Tropical & Public Health Institute
  • Pharmacovigilance & Trial Strategy:
    Post Registration, Safety Monitoring, Planning & Coordinating Clinical Trials (Conrad Savoy, Consultant)
    Case Presentation (Jean-Maurice Dumont, Debiopharm)
  • Keynote: HFG - Federal Act on Research involving Human Beings (Brigitte Meier, BAG)

For more information click here 

Start Date 24.05.2013 - 09:00
Event End 24.05.2013 - 17:00
Location EPFL Lausanne

Newstemp_default.html

Module 4: Clinical Development

CHF 150.00 for members of SBA, swiTT, CTI-start-up companies and academia

This seminar day will focus on challenges and issues for small biotech and academia entering clinical development:

  • Pharma R&D: Issues and Perspectives (Walid Abi-Saab, Shire Pharmaceuticsl)
  • Clinical Phase I-II:
    Phase I/II clinical Trials in the Academic Setting - Benefits for Researchs and Industry(Michael Weisskopf, CTC Zürich)
    Case Presentation (Anya Hamman-Hänni, Cytos)
  • Clinical Phase III:
    Prove Safety & Efficacy in a Large Patient Population (Stephanie Sauter, Five Office)
    Case Presentation: Marc Urich, Swiss Tropical & Public Health Institute
  • Pharmacovigilance & Trial Strategy:
    Post Registration, Safety Monitoring, Planning & Coordinating Clinical Trials (Conrad Savoy, Consultant)
    Case Presentation (Jean-Maurice Dumont, Debiopharm)
  • Keynote: HFG - Federal Act on Research involving Human Beings (Brigitte Meier, BAG)

For more information click here